Hani Salehi-Had MD

12/01/2025

What Is Bull’s-Eye Maculopathy?

Bull’s-eye maculopathy is an eye problem that affects the macula, the part of the retina that helps you see details clearly. It gets its name because the damage creates a ring-shaped pattern, like a bull’s-eye target, and can be caused by genetic eye diseases, certain medications, or other condi...

11/27/2025

Wishing you and your family a wonderful Thanksgiving!

11/20/2025

PERSPECTIVE Trial Launches in Europe.

The PERSPECTIVE trial has commenced in Europe to evaluate the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT) in pseudophakic patients with late-stage age-related macular degeneration (AMD). Conducted across France, Germany, and Italy, the multicenter, randomized study aim...

11/18/2025

Medications and Substances That May Increase Macular Degeneration Risk.

Age-related macular degeneration (AMD) is an eye disease that occurs when the macula — the central part of the retina that controls sharp, straight-ahead vision — is damaged. While AMD is primarily linked to aging, genetics, and smoking, some research suggests that certain medications and habits...

11/13/2025

FDA Clears Gene Therapy Trial for GA.

The FDA has approved the initiation of the Opti-GAIN phase 1/2 clinical trial for CTx001, an adeno-associated virus (AAV)-based gene therapy targeting geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Developed by Complement Therapeutics, CTx001 delivers a truncated versio...

11/11/2025

We thank you for your commitment and celebrate your service.

11/11/2025

EyeCon 2025: The latest on treating ocular surface and cornea disease.

Rahul Tonk, MD, MBA a cornea, cataract, and refractive surgeon from Princeton Eye Group and faculty at Wills Eye Hospital, shared insights on recent advancements in ocular surface disease (OSD) for the EyeCon 2025 conference in Hollywood, Florida. Tonk and Joseph Allen, OD, FAAO, Dipl ABO, gave thei...

11/06/2025

Navigating MacTel From Diagnosis to Therapy.

Macular telangiectasia type 2 (MacTel) is a chronic, progressive, bilateral macular dystrophy that primarily affects individuals in midlife. Characterized by insidious central vision loss and retinal degeneration, it often goes undiagnosed until advanced stages. Recent advancements, such as the appr...

11/04/2025

The #1 Step to Preserve Your Vision With Macular Degeneration.

Age-related macular degeneration (AMD) can cause central vision loss but not complete blindness. Early diagnosis through regular eye exams can slow the progression of AMD.

10/30/2025

Navigating Optogenetics in the IRD Pipeline.

Optogenetics is emerging as a promising gene therapy for advanced inherited retinal diseases (IRDs) like retinitis pigmentosa, Stargardt disease, and Leber congenital amaurosis. By introducing light-sensitive opsins into surviving retinal cells, this approach aims to restore visual function even in....

10/28/2025

A soft micron accuracy robot design and clinical validation for retinal surgery.

Retinal surgery is one of the most delicate and complex operations, which is close to or even beyond the physiological limitation of the human hand. Robots have demonstrated the ability to filter hand tremors and motion scaling which has a promising output in microsurgery. Here, we present a novel s...

10/23/2025

AI Without Borders.

The Global RETFound initiative is a groundbreaking international collaboration aimed at addressing health inequities in ophthalmology. Spearheaded by researchers from institutions such as Moorfields Eye Hospital and University College London, the project seeks to create the world’s first globally ...